Accidental overdose of iron - containing products is a leading cause of fatal poisoning in children under 6 .
KEEP THIS PRODUCT OUT OF THE REACH OF CHILDREN .
In case of accidental overdose , call a doctor or poison control center immediately .
DESCRIPTION CitraNatal ® DHA is a prescription prenatal / postnatal multi - vitamin / mineral tablet with Ferr - Ease ® , a patented dual - iron delivery comprising both a quick release and slow release iron , and a soft gel of an essential fatty acid .
The prenatal vitamin is a white , scored , oval multi - vitamin / mineral tablet .
The tablet is debossed “ CN 1 ” on one side and is blank on the other .
The essential fatty acid DHA soft gel is caramel colored and contains a light yellow to orange semi - solid mixture .
Each prenatal tablet contains : Vitamin C ( Ascorbic acid ) 120 mg Calcium ( Calcium citrate ) 124 mg Iron ( Carbonyl iron , ferrous gluconate ) 27 mg Vitamin D3 ( Cholecalciferol ) 400 IU Vitamin E ( dl - alpha tocopheryl acetate ) 30 IU Thiamin ( Vitamin B1 ) 3 mg Riboflavin ( Vitamin B2 ) 3 . 4 mg Niacinamide ( Vitamin B3 ) 20 mg Vitamin B6 ( Pyridoxine ) 20 mg Folic Acid 1 mg Iodine ( Potassium iodide ) 150 mcg Zinc ( Zinc oxide ) 25 mg Copper ( Cupric oxide ) 2 mg Docusate Sodium 50 mg Each DHA soft gel contains : Other ingredients in DHA soft gel : High oleic sunflower oil , sunflower lecithin , rosemary extract , tocopherols , ascorbyl palmitate .
Docosahexaenoic Acid ( DHA , 40 % from 625 mg Algal Oil ) 250 mg Eicosapentaenoic Acid ( EPA ) Not more than 0 . 625 mg INDICATIONS CitraNatal ® DHA is a multi - vitamin / mineral prescription drug indicated for use in improving the nutritional status of women prior to conception , throughout pregnancy , and in the postnatal period for both lactating and nonlactating mothers .
CONTRAINDICATIONS This product is contraindicated in patients with a known hypersensitivity to any of the ingredients .
WARNING : Ingestion of more than 3 grams of omega - 3 fatty acids per day has been shown to have potential antithrombotic effects , including an increased bleeding time and INR .
Administration of omega - 3 fatty acids should be avoided in patients on anticoagulants and in those known to have an inherited or acquired bleeding diathesis .
WARNING : Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B 12 is deficient .
PRECAUTIONS Folic acid in doses above 0 . 1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress .
ADVERSE REACTIONS Allergic sensitization has been reported following both oral and parenteral administration of folic acid .
DOSAGE AND ADMINISTRATION One tablet and one soft gel daily or as directed by a physician .
STORAGE Store at 20 ° C to 25 ° C ( 68 ° F to 77 ° F ) , excursions permitted between 15 ° C and 30 ° C ( between 59 ° F and 86 ° F ) .
Brief exposure to temperatures up to 40 ° C ( 104 ° F ) may be tolerated provided the mean kinetic temperature does not exceed 25 ° C ( 77 ° F ) ; however , such exposure should be minimalized .
NOTICE : Contact with moisture can discolor or erode the tablet .
HOW SUPPLIED Six child - resistant blister packs of 5 tablets and 5 soft gels each - NDC 0178 - 0894 - 30 .
To report a serious adverse event or obtain product information , call ( 210 ) 696 - 8400 .
Please consult your health care provider with any dietary concerns .
500243 C01 Rev 002140 DHA soft gels manufactured for : MISSION PHARMACAL COMPANY San Antonio , TX USA 78230 1355 Prenatal tablets manufactured by : MISSION PHARMACAL COMPANY San Antonio , TX USA 78230 1355 Copyright © 2014 Mission Pharmacal Company .
All rights reserved .
Citranatal DHA Rx Prenatal Vitamin Tablet and 250 mg DHA Soft Gel Carton NDC 0178 – 0894 – 30 [ MULTIMEDIA ] [ MULTIMEDIA ] Blister Pack [ MULTIMEDIA ] [ MULTIMEDIA ]
